Medizinische Universität Graz - Research portal
Wölfler Albert |
Presentations at scientific and public conferences
Alihodžić, D; Özkaya, E; Foßelteder, J; Sconocchia, T; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Wölfler, A; Vujić, N; Kratky, D; Reinisch, A
Investigating the contribution of TET2 mutant human clonal hematopoiesis to human atherosclerotic plaque formation in a novel LDLR/ApoE double knock-out mouse model.
Doctoral Day 2024; 08.02.2024; Graz, AUSTRIA. 2024.
[Poster]
Alihodžić, D; Özkaya, E; Foßelteder J; Sconocchia, T; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Wölfler A; Vujić, N; Kratky, D; Reinisch A
CRISPR/Cas9 genome engineering to model TET2 mutant human clonal hematopoiesis and its pro-atherogenic potential.
Austrian Atherosclerosis Society (AAS) Annual Meeting; MAI 2-4, 2024; St. Gilgen, AUSTRIA. 2024.
[Poster]
ALIHODŽIĆ, D; ÖZKAYA1, E; PABST, G; FOßELTEDER, J; SCONOCCHIA, T; AUINGER, L; SCHLENKE, P; SILL1, H; ZEBISCH, A; WÖLFLER, A; REINISCH, A
Modeling SRSF2/TET2 mutational cooperativity in CMML development
European Hematology Association (EHA) 2024 Hybrid Congress; JUNE 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Dutta, S; Rezania, S; Lyssy, F; Lind, K; Vosberg, S; Thallinger, G; Zebisch, A; Wölfler, A; Pabst, G; Foßelteder, J; Reinisch, A; Sill, H;
Deciphering the molecular mechanism of mesenchymal stromal cell mediated drug resistance in acute myeloid leukemia.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Kiladjian, JJ; Marin, FF; Al-Ali, HK; Alvarez-Larran, A; Beggiato, E; Bieniaszewska, M; Breccia, M; Buxhofer-Ausch, V; Cerna, O; Crisan, AM; Danaila, C; De Stefano, V; Dohner, K; Empson, V; Tybor, JG; Griesshammer, M; Grosicki, S; Guglielmelli, P; Sr, VGG; Heidel, F; Illes, A; James, C; Koschmieder, S; Maria-Theresa, K; Krejcy, K; Lazaroiu, MC; Mayer, J; Nagy, Z; Palandri, F; Pappa, V; Reiter, A; Sacha, T; Schlager, S; Schmidt, SU; Terpos, E; Tomuleasa, C; Torregrosa, JM; Unger, M; Woelfler, A; Xicoy, B; Klade, C
ROP-ET: A Prospective Phase III Trial Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythemia Patients with Limited Treatment Options
BLOOD. 2024; 144: 6635-6637.
Doi: 10.1182/blood-2024-199028
Web of Science
FullText
FullText_MUG
Lind, K; Dutta, S; Foßelteder, J; Pabst, G; Reinisch, A; Wölfler, A; Zebisch, A; Sill, H;
Deciphering early steps of TP53 aberrant human leukemogenesis.
29th European Hematology Association Congress; JUN 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Puseljic, M; Schmid, J; Igrec, J; Hatzl, S; Scholz, L; Wölfler, A; Fuchsjäger, M; Talakic, E
Seltene pulmonale Manifestationen des VEXAS-Syndroms.
DOI 10.1055/s-0044-1781741
Fortschr Röntgenstr . 2024; 196: S1–S127: 112-113.-105. DEUTSCHER RÖNTGENKONGRESS
10. GEMEINSAMER KONGRESS VON DRG UND ÖRG; MAY 8-10; Wiesbaden, DEUTSCHLAND.
[Oral Communication]
FullText
Lyssy, F; Lind, K; Zöscher, F; Zebisch, A; Wölfler, A; Pabst, G; Fosselteder, J; Reinisch, A; Sill, H; Dutta, S
Modelling drug resistance conferred by mono- and bi-allelic TP53 aberrations using isogenic AML cell lines
ONCOL RES TREAT. 2023; 46: 188-189.
[Poster]
Web of Science
FullText
Egger, M; Lembeck, AL; Woelfler, A; Honigl, M; Tinchon, C; Prattes, J
Burden of invasive fungal infections in patients with haematological malignancies receiving ibrutinib therapy in south-east Austria
MYCOSES. 2022; 65: 38-39.-DMykG; SEP 12 - 14, 2022; Vienna, AUSTRIA.
[Poster]
Web of Science
Le Coutre, P; Petzer, A; Saussele, S; Lang, F; Karsch, D; Herhaus, P; Sliwa, T; Wolfler, A; Breccia, M; Turkina, A; Boquimpani, C; Chuah, C; Sharf, G; Schuld, P; Hoch, M; Yssel, J; Zhang, Y; Hochhaus, A
ASC4OPT Trial in Progress: a Phase 3B Open-label Study to optimize Oral Asciminib Therapy for chronic Myeloid Leukemia in chronic Phase after Pretreatment with 2 TKIs
ONCOL RES TREAT. 2022; 45(SUPPL 2): 122-122.
[Poster]
Web of Science
Lembeck, A; Zebisch, A; Quehenberger, F; Wolfler, A
Pravalenz von Pilz- und Fisch-formigen Erythrozyten in verschiedenen hamatologischen Erkrankungen
ONCOL RES TREAT. 2022; 45(SUPPL 2):290-291.
[Poster]
Web of Science
Pabst, G; Foßelteder, F; Schlacher, A; Auinger, L; Martinez-Krams, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, Ch; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A;
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells.
Blood (2021) 138 (Supplement 1): 2160.. 2022; 138: 2160-2160.-ASH Annual Meeting 2021; DEZ 11-14, 2021; Atlanta, USA.
[Poster]
FullText
Schmitt, L; Bainschab, A; Beham-Schmid, C; Reinisch, A; Zitta, S; Wölfler, A
Renal function in patients with BCR-ABL-negative myeloproliferative neoplasms
OeGHO Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA. 2022.
[Poster]
Schranz, A; Sternad, C; Mischinger, HJ; Wagner, D; Jost, PJ; Riedl, J; Wolfler, A; Pieber, T; Sourij, H; Aberer, F
Incidence of diabetes and its impact on survival after pancreatic tumor surgery - a retrospective data analysis
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):258-259.-Jahrestagung der Österreichischen Diabetesgesellschaft ;
[Poster]
Web of Science
Telebar, F; Berg, JL; Perfler, B; Bramreiter, B; Caraffini, V; Prokesch, A; Geissler, K; Penz, T; Schuster, M; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A;
Co-occurrence of mutations modifying RAS and EZH2 inactivation in chronic myelomonocytic leukemia causes amplification of RAS-AKT signaling and increases the sensitivity to AKT inhibitors
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo 15 (Suppl 3), 37–67 (2022). . 2022; 15( ):S65--OeGHO- & AHOP-Frühjahrstagung 2022; April 8-10, 2022; Graz, Austria.
[Oral Communication]
FullText
Berg, JL; Perfer, B; Hatzl, S; Reinisch, A; Pregartner, G; Klymiuk, I; Tierling, S; Geissler, G; Strobl, H; Berghold, A; Wölfer, A; Sill, H; Zebisch, A
Aberrant expression of micro-RNA-125a plays a role in the pathogenesis and treatment of chronic myelomonocytic leukemia – Update
memo - Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2021; 14: -Annual Meeting of the Austrian Society
of Haematology and Medical Oncology; APR 8-10, 2021; Wien.
[Poster]
Foßelteder, J; Rosenberger, A; Pabst, G; Sill, H; Wölfler, A; Reinisch, A
Calreticulin mutations transform healthy hematopoietic stem cells into myeloproliferative neoplasms.
Doctoral Day 2021 at Medical University of Graz; FEB 12, 2021; Graz, AUSTRIA. 2021.
[Onlinepräsentation]
Foßelteder, J; Schlacher, A; Pabst, G; Amtmann, B; Schöll, W; Kashofer, K; Beham-Schmid, C; Schlenke, P; Greinix, HT; Sill, H; Woelfler, A; Zebisch, A; Reinisch, A
Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-147919
[Poster]
Web of Science
FullText
FullText_MUG
Pabst, G; Foßelteder, J; Schlacher, A; Auinger, L; Martinez-Krams3, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, C; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-149591
[Poster]
Web of Science
FullText
FullText_MUG
Tomic, J; Acham, S; Jaske, N; Schanbacher, M; Gary, T; Wölfler, A; Raggam, R;
Zemann, W.
Das 2021 Update der Empfehlungen der Österreichischen Arbeitsgruppe Mund-, Kiefer- und Gesichtschirurgie und Orale Chirurgie bezüglich perioperativer Antikoagulation
62. Österr. Chirurgenkongress. 2021; -62. Österr. Chirurgenkongress; JUN 8- 11, 2021; Salzburg.
[Oral Communication]
Wölfler, A
Risiko-Benefit Abschätzung in der MPN Behandlung
Österreichisches Hämatologie Experten Meeting; Oct 8,2021; Wien, Österreich. 2021.
[Oral Communication]
Wölfler, A
Covid-19: Rolle der TKI Therapie für Verlauf und Impferfolg.
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Oct 1-4, 2021; Berlin, Germany. 2021.
[Oral Communication]
Wölfler, A
Neue zugelassene Substanzen bei der AML: Chancen und Pitfalls.
ÖGHO Frühjahrestagung ; Apr 8-10, 2021; Wien, Österreich. 2021.
[Oral Communication]
Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N
Massive cardiac AL amyloidosis in the absence of monoclonal gammopathy.
WIEN KLIN WOCHENSCHR. 2020; 132: S237-S237.
[Poster]
Web of Science
FullText
Zach, D; Ablasser, K; Kolesnik, E; Fruhwald, F; Pruller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Zirlik, A; Wolfler, A; Verheyen, N
The exceptional Case of massive cardiac AL-Amyloidosis with missing monoclonal Gammopathy.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):73-73.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Poster]
Web of Science
Berg, JL; Perfler, B; Hatzl, S; Reinisch, A; Geissler, K; Strobl, H; Wölfler, A; Sill, H; Zebisch, A
Expression of miR-125a is decreased in chronic myelomonocytic leukemia and of relevance for the treatment with 5-azacytidine
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology, Magazine of European Medical Oncology. 2019; 12: 53--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Foßelteder, J; Wölfler, A; Kargl, J; Schöll, W; Schlenke, P; Sill, H; Reinisch, A
In-vitro modeling of JAK2 V617F-driven myeloproliferative neoplasms
using CRISPR/Cas9 genome engineering.
DocDay 2019, Medical University of Graz; 21.11.2019; Graz, AUSTRIA. 2019.
[Poster]
Gornicec, M; Reinisch, A; Hatzl, S; Schilcher, G; Wölfler, A; Schulz, E
Sustained complete remission with Ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis: a case report
Oncol Res Treat 2019;42(suppl 4):1-336. 2019; -Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 11-14, 2019; Berlin, GERMANY.
[Poster]
FullText
Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, C; St. John, J; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher,M
Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, Israel. 2019.
[Poster]
FullText
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wolfler, A; Sill, H; Zebisch, A
Loss of RKIP expression is a frequent event in chronic myelomonocytic leukemia and functionally involved in the pathogenesis of this malignancy
ONCOL RES TREAT. 2018; 41: 27-27.
[Oral Communication]
Web of Science
Daga, S; Rosenberger, A; Krisper, N; Prietl, B; Reinisch, A; Zebisch, A; Sill, H; Wolfler, A
GPR56 and CLL-1 (CLEC12A) as putative leukemic stem cell markers in CD34-positive acute myeloid leukemia
ONCOL RES TREAT. 2018; 41: 73-73.
[Poster]
Web of Science
Daga, S; Rosenberger, A; Krisper, N; Reinisch, A; Zebisch, A; Sill, H; Wölfler, A
GPR56 is a putative marker of leukemic stem cells in CD34-positive acute myeloid leukemia.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2018; Supplement 1/18: -Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA.
[Poster]
Daga, S; Rosenberger, A; Krisper, N; Wölfler, A
Limitation of CLL-1 (CLEC12A) as a putative marker of leukemic stem cells in acute myeloid leukemia.
Annual Meeting of the Belgian Hematology Society; FEB 2-3, 2018; Brussels, BELGIUM. 2018.
[Poster]
Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wolfler, A; Sill, H; Zebisch, A
Deregulation of the micro-RNA-23a/TOP2B axis causes resistance to cytarabine in acute myeloid leukemia
ONCOL RES TREAT. 2018; 41: 243-243.
[Oral Communication]
Web of Science
Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A
Increased expression of micro-RNA-23a causes resistance to cytarabine in acute myeloid leukemia.
Proceedings of the Annual Meeting of the
Austrian Society of Haematology and Medical Oncology
. 2018; Supplement 1/18: 26-26.-Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA.
[Oral Communication]
Heldt, S; Prattes, J; Eigl, S; Spiess, B; Flick, H; Rabensteiner, J; Johnson, G; Pruller, F; Wolfler, A; Niedrist, T; Boch, T; Neumeister, P; Strohmaier, H; Krause, R; Buchheidt, D; Hoenigl, M
Invasive Aspergillosis: Performance of New and Established Diagnostic Approaches with Same-Day Blood and Bronchoalveolar Lavage - a Prospective Cohort Study
MED MYCOL. 2018; 56: S34-S34.
[Poster]
Web of Science
Heldt, S; Prattes, J; Eigl, S; Spiess, B; Flick, H; Rabensteiner, J; Johnson, G; Prüller, F; Wölfler, A; Niedrist, T; Boch, T; Neumeister, P; Strohmaier, H; Krause, R; Buchheidt, D; Hoenigl, M
Invasive Aspergillosis: Performance of New and Established Diagnostic Approaches with Same-Day Blood and Bronchoalveolar Lavage – a Prospective Cohort Study
Medical Mycology, ISHAM 2018 abstract supplement. 2018; 56(S2):34-34.-20th Congress of the International Society for Human and Animal Mycology; JUN 30-JUL 4, 2018; Amsterdam, Netherlands.
[Oral Communication]
FullText
Muralikrishnan, AS; Rosenberger, A; Schwarzenberger, E; Strobl, H; Zebisch, A; Sill, H; Wolfler, A
A role of C/EBP alpha in early dendritic cell development
ONCOL RES TREAT. 2018; 41: 102-102.
[Poster]
Web of Science
Pabst, G; Prochazka, K; Pregartner, G; Rücker, FG; Heitzer, E; Woelfler ,A; Zebisch, A; Berghold, A; Döhner, K; Sill H.
Impact of TP53 mutated subclones in acute myeloid leukemia
Blood. 2018; 132(Suppl ):-Annual Meeting of the American Society of Hematology; December 1-4, 2018; San Diego.
Doi: 10.1182/blood-2018-99-110667
[Poster]
Web of Science
FullText
FullText_MUG
Wolfler, A
Management of side effects of tyrosine kinase inhibitors
ONCOL RES TREAT. . 2018; 41: 229-229.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28-OCT 2, 2018; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Aberer, F; Holzgruber, J; Tripolt, NJ; Mader, JK; Pieber, TR; Greinix ,H; Zebisch, A; Woelfler, A; Sourij, H
A pilot trial to investigate efficacy and safety of an automized decision support system for the treatment of steroid induced hyperglycemia in patients with acute Graft-versus-host disease
Diabetes.. 2017; 66(S1):A669-A669.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.
Aberer, F; Holzgruber, J; Tripolt, NJ; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Pieber, TR; Wölfler, A; Sourij, H
Efficacy and safety of an insulin decision support system in the treatment of steroid hyperglycaemia in patients with graft-versus- host-disease: a randomised pilot trial.
Diabetologia. 2017; 60(S1):S323-S324.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Poster]
Web of Science
Aberer, F; Mader, JK; Stauber, M; Neumeister, P; Oulhaj, Abderrahim; Zebisch, A; Pieber, TR; Greinix, H; Sill, H; Woelfler, A; Sourij, H
Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-vs.-Host Disease.
Diabetes.. 2017; 66(S1):A24-A25.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.
[Oral Communication]
Aberer, F; Mader, JK; Stauber, M; Tripolt, N; Holzgruber, J; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, H; Sill, H; Wölfler, A; Sourij, H
Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease.
4th International Hospital Diabetes Meeting. 2017; MAY 19-20, 2017; Atlanta, USA.
[Poster]
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Woelfler, A; Sill, H; Zebisch, A
LOSS OF RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN MYELOMONOCYTIC LINEAGE COMMITMENT AND AGGRAVATES THE DEVELOPMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN A MURINE IN-VIVO MODEL
HAEMATOLOGICA. 2017; 102: 148-149.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, P; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wölfler, A; Sill, H; Zebisch, A
RAF kinase inhibitor protein is involved in the development of chronic myelomonocytic leukemia
memo - Magazine of European Medical Oncology. 2017; 10(2):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]
Caraffini, V; Schauer, S; Kashofer, K; Wolfler, A; Hoefler, G; Sill, H; Zebisch, A
RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN THE DEVELOPMENT OF MYELOID SARCOMA
HAEMATOLOGICA. 2017; 102: 361-362.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Poster]
Web of Science
Caraffini, V; Schauer, S; Kashofer, K; Wölfler, A; Hoefler, G; Sill, H; Zebisch A
Loss of RAF kinase inhibitor Protein in myeloid sarcoma
memo - Magazine of European Medical Oncology
. 2017; 10(2):31-31.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology
; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]
Daga, S; Krisper, N; Wölfler, A.
GPR56 is a putative leukemic stem cell marker with prognostic significance in acute myeloid leukemia.
9th ÖGMBT Annual Meeting ; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017.
[Poster]
Daga, S; Krisper, N; Zebisch, A; Sill, H; Wölfler, A
GPR56 is a putative leukemic stem cell marker with prognostic significance in acute myeloid leukemia.
4th International Conference on Acute Myeloid Leukemia; OCT 5-7, 2017; Estoril, PORTUGAL. 2017.
[Poster]
Gaksch, L; Kashofer, K; Heitzer, E; Daga, S; Hofer, S; Krisper, N; Hofler, G; Zebisch, A; Sill, H; Wolfler, A
Persistence of non-DNMT3A mutations predicts relapse in cytogenetically normal AML
ONCOL RES TREAT. 2017; 40: 140-141.
[Oral Communication]
Web of Science
Heldt, S; Eigl, S; Prattes, J; Flick, H; Rabensteiner, J; Neumeister, P; Prueller, F; Strohmaier, H; Krause, R; Wölfler, A; Hoenigl, M
Levels of IL-6, IL-8, IL-10 and IL-17A in serum and IL-8 in bronchoalveolar lavage fluid are elevated in haematological patients with invasive pulmonary aspergillosis
27th ECCMIDLive Programme Overview, Session Diagnostic mycology I, Abstract and ePoster. 2017; -27th European Congress of Clinical Microbiology and Infectious Diseases; APR 22-25, 2017; Vienna, AUSTRIA.
[Poster]
FullText
Heldt, S; Eigl, S; Prattes, J; Flick, H; Rabensteiner, J; Prueller, F; Niedrist, T; Neumeister, P; Obersteiner, S; Ober, J; Wolfler, A; Krause, R; Strohmaier, H; Hoenigl, M
Levels of interleukin-6 and-8 in serum and bronchoalveolar lavage fluid are elevated in haematological malignancy patients with invasive pulmonary aspergillosis: A nested case control study
MYCOSES. 2017; 60: 101-102.-TIMM; OCT 6-9, 2017; Belgrade, SERBIA.
[Poster]
Web of Science
Heldt, S; Eigl, S; Prattes, J; Flick, H; Rabensteiner, J; Prueller, F; Niedrist, T; Neumeister, P; Obersteiner, S; Ober, J; Wölfler, A; Krause, R; Strohmaier, H; Hoenigl, M
Levels of interleukin-6 and -8 in serum and bronchoalveolar lavage fluid are elevated in haematological malignancy patients with invasive pulmonary aspergillosis: A nested case control study.
--. 2017; -8th Trends in Medical Mycology; OCT 6-9, 2017; Belgrade, SERBIA.
[Poster]
Heldt, S; Eigl, S; Prattes, J; Rabensteiner, J; Flick, H; Neumeister, P; Niedrist, T; Ober, J; Obersteiner, S; Prueller, F; Strohmaier, H; Krause, R; Wölfler, A; Hoenigl, M
Levels of Interleukin-6 and -8 in bronchoalveolar lavage fluid are elevated in haematological patients with invasive pulmonary aspergillosis: A case control study.
--. 2017; -51. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e. V.; AUG 31-SEP 2, 2017; Münster, GERMANY.
[Oral Communication]
Heldt, S; Eigl, S; Prattes, J; Rabensteiner, J; Flick, H; Neumeister, P; Niedrist, T; Ober, J; Obersteiner, S; Prueller, F; Strohmaier, H; Krause, R; Wolfler, A; Hoenigl, M;
Levels of interleukin-6 and-8 in bronchoalveolar lavage fluid are elevated in haematological patients with invasive pulmonary aspergillosis: A case control study.
MYCOSES. . 2017; 60: 6-7.-51. wiss. Tagung der deutsschrachigen Mykologischen Gesellschaft; AUG 21 - SEPT 2, 2017; Münster.
[Oral Communication]
Web of Science
Heldt, S; Eigl, S; Prattes, J; Rabensteiner, J;
Flick, H; Neumeister, P; Prueller, F; Strohmaier, H;
Krause, R; Wölfler, A; Obersteiner, S; Hoenigl, M
Aspergillus fumigatus induces elevated cytokine-levels in serum and bronchoalveolar lavage fluid of hematological malignancy patients: A prospective study.
Programmheft 11. Österreichischer Infektionskongress 2017 mit Abstracts. 2017; 55--11. Österreichischer Infektionskongress; MAR 29-APR 1, 2017; Saalfelden, AUSTRIA.
[Oral Communication]
FullText
Kashofer, K; Gornicec, M; Caraffini, V; Lind, K; Schauer, S; Beham-Schmid, C; Wölfler, A; Hoefler, G; Sill, H; Zebisch, A
Genetic aberrations of myeloid sarcomas
memo - Magazine of European Medical Oncology
. 2017; 10(2):28-28.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology
; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]
Petzer, A; Herndlhofer, S; Weltertnann, A; Sliwa, T; Schmidt, S; Greil, R; Wolfler, A; Wiesholzer, M; Dormann, C; Thaler, J; Tinchon, C; Ruckser, R; Lang, A; Hanig, J; Winiger, I; Muenchmeier, N; Sperr, WR
R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting
ONCOL RES TREAT. 2017; 40: 58-58.
[Poster]
Web of Science
Schmidt, V; Zebisch, A; Hofer, S; Steinwender, D; Höfler, G; Beham-Schmid, C; Sill, H; Wölfler, A
Analysis of criteria for tyrosine kinase Inhibitor discontinuation in CML patients in a real-life setting
memo - Magazine of European Medical Oncology. 2017; 10(2):26-26.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology
; APR 6-8, 2017; Bregenz, AUSTRIA.
[Poster]
Stauber, M; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A
Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S285-S285.
Web of Science
Subramanian, A; Rosenberger, A; Schwarzenberger, E; Strobl, H; Zenisch, A; Sill, H; Wölfler, A
A role of C/EBPa in early dendritic cell development.
FEBS Immunology Summer School; SEP 23-30, 2017; Hvar, CROATIA. 2017.
[Poster]
Aberer, F; Holzgruber, J; Mader, JK; Wölfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H
Pilotstudie zur Überprüfung der Machbarkeit und Effizienz
einer normnahen Blutzuckereinstellung mittels eines
automatisierten Entscheidungsunterstützungsalgorithmus
in der Insulintherapie von Patienten mit Graft-versus-host
Erkrankung
Wiener klinische Wochenschrift . 2016; 44(6):410-410.-Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17,19, 2016; Salzburg .
[Poster]
Aberer, F; Kremser, S; Zebisch, A; Mader, JK; Sill, H; Greinix, H; Zinke-Cerwenka, W; Pieber, TR; Oulhaj, A; Wölfler, A; Sourij, H
Hyperglycemia during the First Month after Allogeneic Hematopoietic
Stem Cell Transplantation Is an Independent Risk Factor for
Overall Survival in Patients with Acute Myeloid Leukemia.
Diabetes. 2016; 65(S1):A410-A411.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA.
[Poster]
Aberer, F; Mader, JK; Wolfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H
Pilot Study for Verifying the Feasibility and Efficiency of a standard Blood Glucose Control using an automated Decision Support Algorithm in the Insulin Therapy of Patients with Graft-versus-host Disease
WIEN KLIN WOCHENSCHR. 2016; 128: S407-S407.-44. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA.
[Poster]
Web of Science
Aberer, F; Stauber, M; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Oulhaj, A; Pieber, TR; Wölfler, A; Sourij, H
In-Hospital Hyperglycemia Is Associated with Adverse Outcome in
Patients with Acute or Chronic Graft vs. Host Disease after Hematopoeietic Stem Cell Transplantation.
Diabetes. 2016; 65(S1):A390-A390.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA.
[Poster]
Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wölfler, A; Sill, H; Zebisch, A
Antibiotic prophylaxis is associated to a decreased rate of infections in AML patients treated with low-intensity therapeutic regimens
memo - Magazine of European Medical Oncology . 2016; 9(1):20-20.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA.
[Poster]
Gaksch, L; Kashofer, K; Daga, S; Hofer, S; Höfler, G; Zebisch, A; Sill, H; Wölfler A
Mutation clearance detected by parallel
sequencing at end of treatment: impact on
relapse-free survival in intermediate-risk AML
patients
memo - Magazine of European Medical Oncology . 2016; 9(1):3-3.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA.
[Oral Communication]
Gaksch, L; Kashofer, K; Heitzer, E; Daga, S; Hofer, S; Krisper, N; Höfler, G; Zebisch, A; Sill, H; Wölfler A
Persitence of non-DNMT3A mutations predicts relapse in cytogenetically normal AML.
Oncol Res Treat 2016. 2016; 39(suppl3):140--Jahrestagung DGHO; OCT 14-18,2016; Leipzig. (ISBN: 2296-5270 )
[Oral Communication]
Web of Science
Heldt, S; Eigl, S; Buchheidt, D; Prattes, J; Krause, R; Woelfler, A; Prueller, F; Spiess, B; Hoenigl, M; Boch, T
Galactomannan Testing and Aspergillus PCR in Same-Day Bronchoalveolar Lavage and Blood Samples for Diagnosis of Invasive Mould Infections.
Online collection of accepted abstracts at IDWeek 2016. 2016; -IDWeek; OKT 26-30, 2016; New Orleans, USA.
[Poster]
FullText
Lal, R; Lind, K; Kashofer, K; Heitzer, E; Ulz, P; Troppmair, J; Hofer, S; Schulz, E; Mathre, K; Wölfler, A; Zebisch, A; Sill, H
TP53 mutations in acute myeloid leukemia affect pre-leukemic stem cells
memo - Magazine of European Medical Oncology . 2016; 0(1):19-20.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA.
[Poster]
Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Rankl, J; Hofer, S; Mueller, M; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Woelfler, A; Zebisch, A; Sill, H
IMPAIRED BASE EXCISION REPAIR GLYCOSYLASE/AP ENDONUCLEASE ACTIVITY CONTRIBUTES TO CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA
HAEMATOLOGICA. 2016; 101: 211-212.
[Poster]
Web of Science
Prattes, J; Reischies, FMJ; List, A; Raggam, RB; Eigl, S; Zollner-Schwetz, I; Valentin, T; Woelfler, A; Prueller, F; Flick, H; Krause, R; Hoenigl, M
Diagnostic Performance of 1,3-beta-d-glucan Serum Screening in Patients Receiving Hematopoietic Stem Cell Transplantation versus Hematological Patients without Stem Cell Transplantation
. 2016; -ASM Conference on Candida and Candidiasis; APR 13-17, 2016; Seattle, USA.
[Poster]
Stauber, M; Aberer, F; Zebisch, A; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wölfler, A
Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease
memo - Magazine of European Medical Oncology . 2016; 9(1):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA.
[Poster]
Aberer, F; Mader, JK; Kremser, S; Zinke-Cerwenka, W; Greinix, H; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Wölfler, A; Sourij, H
Glykämie nach allogener Stammzelltransplantation bei Patienten mit akuter myeloischer Leukämie (AML) ist ein unabhängiger Prädiktor für das Überleben.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S135.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
Aberer, F; Stauber, MN; Mader, JK; Greinix, H; Oulhaj, A; Wölfler, A; Sourij, H
Assoziation zwischen Hyperglykämie und ungünstigem Outcome bei Patienten mit akuter oder chronischer Graft-versus-Host Erkrankung (GvHD) nach allogener Stammzelltransplantation.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S156-S157.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wolfler, A; Sill, H; Zebisch, A
Efficacy of antibiotic prophylaxis in AML patients treated with low-intensity therapeutic regimens
ONCOL RES TREAT. 2015; 38: 73-74.
[Poster]
Web of Science
Gaksch, L; Kashofer, K; Höfler, G; Tinchon, C; Krippl, P; Zebisch, A; Greinix, H; Sill, H; Wölfler, A
Feasibility of next generation sequencing for routine diagnostic genetic profiling in myeloid malignancies.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA.
[Poster]
Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nußbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A
Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
Oncology Research and Treatment. 2015; 38: -Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OKT 9-13, 2015; Basel, SWITZERLAND. (ISBN: 978-3-318-02811-9 )
[Oral Communication]
Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wolfler, A; Troppmair, J; Sill, H; Zebisch, A
Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
ONCOL RES TREAT. 2015; 38: 99-99.
[Oral Communication]
Web of Science
Hatzl, S; Geiger, O; Nußbaumer, E; Rosenberger, A; Troppmair, J; Kolch, W; Blyth, K; Sill, H; Woelfler, A; Zebisch, A
RAF kinase inhibitor protein is involved in the myelomonocytic differentiation of hematopoietic progenitors.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(S1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA.
[Poster]
Kremser, S; Aberer, F; Zinke-Cerwenka, W; Neumeister, P; Zebisch, A; Greinix, H; Sill, H; Sourij, H; Wölfler, A
Hyperglycemia is an adverse risk factor in AML patients undergoing allogeneic hematopoietic stem cell transplantation.
memo-magazine of european medical oncology; 2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(S1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA.
[Poster]
Nußbaumer, E; Hatzl, S; Kuepper, K; Geiger, O; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Lavrencic, M; Woelfler, A; Troppmair, J; Sill, H; Zebisch, A
Loss of RAF kinase inhibitor protein in acute myeloid leukemia is caused by the overexpression of miRNA-15a.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, VIENNA.
[Poster]
Reischies, FM; Prattes, J; Eigl, S; List, A; Raggam, RB; Zollner-Schwetz, I; Valentin, T; Flick, H; Woelfler, A; Prueller, F; Krause, R; Hoenigl, M
Bronchoalveolar Lavage 1,3-Beta-D-Glucan Testing for Prediction of Overall 30-day Mortality
MYCOSES. 2015; 58: 110-110.
[Poster]
Web of Science
Reischies, FM; Prattes, J; Eigl, S; List, A; Raggam, RB; Zollner-Schwetz, I; Valentin, T; Flick, H; Woelfler, A; Prueller, F; Krause, R; Hoenigl, M
Diagnostic performance of 1,3-beta-d-glucan Serum Screening in Patients receiving Hematolopoietic Stem Cell Transplantation
MYCOSES. 2015; 58: 159-159.
[Poster]
Web of Science
Reischies, FM; Prattes, J; Eigl, S; List, A; Raggam, RB; Zollner-Schwetz, I; Valentin, T; Flick, H; Woelfler, A; Prueller, F; Krause, R; Hoenigl, M
Calculation of the Galactomannan-Creatinine Index improves the Diagnostic Performance of Galactomannan testing from Urine Samples
MYCOSES. 2015; 58: 110-110.
[Oral Communication]
Web of Science
Reischies, F.M.J; Prattes, J; Eigl, S; List, A ; Valentin, T ; Zollner-Schwetz, I; Raggam, R.B; Prueller, F; Rabensteiner, J; Flick, H; Woelfler, A; Krause, R; Hoenigl, M
Calculation of the Galactomannan-Creatinine Index Improves the Diagnostic Performance of Galactomannan Testing from Urine Samples
MYCOSES. 2015; -7th Trends in Medical Mycology (TIMM); Oct 9-12, 2015; Lisbon, PORTUGAL.
[Poster]
Reischies, F.M.J; Prattes, J; Eigl, S; List, A ; Valentin, T ; Zollner-Schwetz, I; Raggam, R.B; Prueller, F; Rabensteiner, J; Flick, H; Woelfler, A; Krause, R; Hoenigl, M
Prognostic Potential of 1,3-Beta-D-Glucan Levels in Bronchoalveolar Lavage Fluid Samples
MYCOSES. 2015; -7th Trends in Medical Mycology (TIMM); Oct 9-12, 2015; Lisbon, PORTUGAL.
[Poster]
Rief, P; Hackl, G; Hafner, F; Raggam, RB; Wölfler, A; Brodmann, M; Gary, T
VTE during Pressence of acquired Inhibitor to Coagulation factor V - A case report
Z f Gefäßmedizin. 2015; -Sailersymposium; Jun 18-19, 2015; Graz.
[Oral Communication]
Rief, P; Hackl, G; Hafner, F; Raggam, RB; Wölfler, A; Brodmann, M; Gary, T;
Venous thromboembolism during concomitant presence of acquired inhibitor to coagulation factor V – A case report
10. Sailersymposium 2015; Jun 18-20, 2015; Graz, Austria. 2015.
[Poster]
Rief, P; Hackl, G; Hafner, F; Raggam, Reinhard Bernd; Wölfler, Albert; Brodmann, Marianne; Gary, Thomas
Erworbene, idiopathische Hemmkörper-Hämophilie gegen Faktor V – Ein Fallbericht
VASCMED 2015; Oct 22-24, 2015; Innsbruck, Austria. 2015.
[Oral Communication]
Rosenberger, A; Geiger, O; Zebisch, A; Sill, H; Wolfler, A
C/EBP alpha-induced proinflammatory cytokines regulate early dendritic cell development
ONCOL RES TREAT. 2015; 38: 249-250.
[Poster]
Web of Science
Schlager, S; Goeritzer, M; Jandl, K; Frei, R; Vujic, N; Kolb, D; Strohmaier, H; Dorow, J; Eichmann, TO; Wölfler, A; Ceglarek, U; Heinemann, A; Kratky, D
ATGL acts on neutrophil lipid droplets to generate lipid mediators
22nd Annual Meeting of the Austrian Atherosclerosis Society
; May 8-9, 2015;; St. Gilgen, AUSTRIA. 2015.
[Oral Communication]
Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Pober, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G
UPDATED REPORT OF THE AUSTRIAN CML-REGISTRY
HAEMATOLOGICA. 2015; 100: 693-693.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Wiesholzer, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G
Tyrosin kinase inhibitors usage and response analysis in the Austrian CML registry cohort
ONCOL RES TREAT. 2015; 38: 133-133.
[Poster]
Web of Science
Stauber, M; Aberer, F; Zebisch, A; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A
Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease
ONCOL RES TREAT. 2015; 38: 129-129.
[Poster]
Web of Science
Vujic, N; Schlager, S; Eichmann, TO; Goeritzer, M; Woelfler, A; Lass, A; Zimmermann, R; Hoefler, G; Radovic, B; Kratky, D
Monoglyceride lipase inhibition as potential target for atherosclerotic plaque
stabilization
22nd Annual Meeting of the Austrian Atherosclerosis Society; May 8-9, 2015; St. Gilgen, Austria. 2015.
[Oral Communication]
Duettmann, W; Koidl, C; Woelfler, A; Wagner, J; Lackner, G; Raggam, RB; Petricevic, B; Neumeister, P; Krause, R; Hoenigl, M
Comparision of Mannan/Anti-Mannan and 1,3-Beta-D-Glucan Screening for Invasive Candida Infection in Patients with Hematologic Malignancies
ICAAC ; SEPT 5-9, 2014; Washington D.C., USA. 2014.
[Poster]
Duttmann, W; Wolfler, A; Koidl, C; Wagner, J; Lackner, G; Raggam, R; Petricevic, B; Neumeister, P; Krause, R; Honigl, M
Comparision of Mannan/Anti-Mannan and 1,3-beta-D-Glucan Screening for Invasive Candida Infection in Patients with Hematologic Malignancies
MYCOSES. 2014; 57: 33-34.
[Poster]
Web of Science
Eigl, S; Fischbach, L; Prattes, J; Duttmann, W; Koidl, C; Huber-Krassnitzer, B; Neumeister, P; Wagner, J; Wolfler, A; Krause, R; Hoenigl, M
Serum and Urine Galactomannan testing for screening in patients with hematological malignancies
MYCOSES. 2014; 57: 24-24.
[Oral Communication]
Web of Science
Hoenigl, M; Duettmann, W; Huber-Krassnitzer, B; Wagner, J; Prattes, J; Troppan, K; Seeber, K; Raggam, RB; Wolfler, A; Krause, R
CORRELATION OF EARLY TROUGH LEVELS (DAY 4) WITH STEADY-STATE
POSACONAZOLE PLASMA CONCENTRATIONS - A COHORT STUDY.
. 2014; -24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); MAY 10-13, 2014; Barcelona, Spain.
[Poster]
Hoenigl, M; Duettmann, W; Raggam, RB; Wolfler, A; Huber-Krassnitzer, B; Neumeister, P; Prattes, J; Hönigl, K; Drescher, M; Wagner, J; Valentin, T; Zollner-Schwetz, I; Krause, R
Impact Of Structured On-site Patient Education On Low Posaconazole Plasma
Concentrations.
.. 2014; -8. Österreichischer Infektionskongress; APR 2-5, 2014; Saalfelden, AUSTRIA.
[Poster]
Hoenigl, M; Duettmann, W; Seeber, K; Wolfler, A; Huber-Krassnitzer, B; Prattes, J; Troppan, K; Raggam, RB; Semmelrock, H; Prueller, F; Wagner, J; Krause, R
Posaconazole Plasma Concentrations: Correlation of Early Trough Levels (day 4) with Steady-State Concentrations.
. 2014; -6th Advances Against Aspergillosis; FEB 27 - MAR 1; Madrid, SPAIN.
[Poster]
Kuepper, MK; Wolf, O; Huber-Krassnitzer, B; Wieser, R; Pichler, M; Scheideler, M; Woelfler, A; Sill, H; Zebisch, A
Overexpression of miR-23a, miR-24 and miR-15a in acute myeloid leukemia with loss of the RAF kinase inhibitor protein.
memo-magazine of european medical oncology 2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Oral Communication]
Lind, K; Olipitz, W; Monsberger, N; Katschnig, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Wölfler, A; Zebisch, A; Sill, H
Defizienz der Basen-Exzisions-Reparatur (BER) bei akuter myeloischer Leukämie (AML).
memo-magazine of european medical oncology
2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Poster]
Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Woelfler, A; Zebisch, A; Sill, H
Base Excision Repair Glycosylase Activity Is Impaired in a Subgroup of Acute Myeloid Leukemia Resulting in Increased Levels of Oxidative Base Lesions
BLOOD. 2014; 124(21):-56th Annual Meeting of the American-Society-of-Hematology; DEC 06-09, 2014; San Francisco, CA.
[Poster]
Web of Science
Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Wölfler, A; Zebisch, A; Sill, H
Base excision repair glycosylase activity is impaired in a subgroup of acute myeloid leukemia resulting in increased levels of oxidative base lesions
Oncol Res Treat. 2014; 37(S5):49-49.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
[Poster]
Web of Science
Prüller, F; Bauer, F; Raggam, RB; Kohek, P; Zotter, M; Münch, A; Horina, J; Wölfler, A; Huber-Krassnitzer, B; Preininger, A
Delayed Diagnosis of Severe Acquired Haemphilia in a Post-surgical ICU Patient after Treatment with New Oral Anticoagulants
Hämostaseologie. 2014; 34(1):-58th Annual Meeting Society of Thrombosis and Haemostasis Research - Translational medicine on the road to tailored therapies; FEB 1215, 2014; Vienna, AUSTRIA.
[Poster]
Reischies, F; Prattes, J; Eigl, S; Lackner, M; Duettmann, W; Posch, V; Spiess, B; Wolfler, A; Honigl, K; Koidl, C; Raggam, RB; Thornton, CR; Krause, R; Buchheid, D; Willinger, B; Lass-Florl, C; Hoenigl, M
Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU and Haematological patients
MYCOSES. 2014; 57: 34-34.
[Poster]
Web of Science
Rosenberger, A; Wolf, O; Zebisch, A; Touw, I; Sill, H; Wölfler, A
Myeloid progenitors contribute to formation of plasmacytoid dendritic cells in the thymus.
memo-magazine of european medical oncology
2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Poster]
Schlager, S.; Göritzer, M; Jandl, K; Frei, R; Kolb-Lenz, D; Strohmaier, H; Wölfler, H; Schweiger, M; Heinemann, A; Kratky, D
Functional consequences of Jordans’ anomaly caused by ATGL deficiency: Effect on eicosanoid biosynthesis.
Doctoral Day 2014- Medical University of Graz; DECEMBER, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Schlager, S; Jandl, K; Frei, R; Kolb-Lenz, D; Strohmaier, H; Wölfler, A; Eichmann, T; Heinemann, A; Kratky, D
ATGL-deficient mice exhibit Jordans’ anomaly.
Keystone Symposium “Lipid pathways in biology and disease”; MARCH ,2014; Dublin, IRELAND. 2014.
[Poster]
Schlager, S; Jandl, K; Goeritzer, M; Frei, R; Kolb-Lenz, D; Strohmaier, H; Wölfler, A; Eichmann, T; Heinemann, A; Kratky, D
Functional consequences of Jordans’ anomaly caused by ATGL deficiency.
FASEB Meeting “Lipid Droplets and Metabolic Consequences of Neutral Lipid Storage”; JULY, 2014; Saxtons River, VT, USA. 2014.
[Poster]
Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Najima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Geigl, JB; Höfler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H
Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X
Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
[Oral Communication]
Web of Science
Vujic, N; Schlager, S; Eichmann, TO; Goeritzer, M; Woelfler, A; Lass, A; Radovic, B; Kratky, D
Improved plaque stabilization despite increased atherosclerotic plaque size in apolipoprotein E-deficient mice lacking monoacylglycerol lipase
Doctoral Day 2014; Dec 10, 2014; Graz, Austria. 2014.
[Oral Communication]
Vujic, N; Schlager, S; Eichmann, TO; Goeritzer, M; Woelfler, A; Lass, A; Zimmermann, R; Radovic, B; Kratky, D
Improved plaque stabilization despite increased atherosclerotic plaque size in apolipoprotein E-deficient mice lacking monoacylglycerol lipase
4th Scientific Retreat; Oct 30 -Nov 1, 2014; Schloss Seggau, Austria. 2014.
[Oral Communication]
Wolf, O; Schulz, E; Theiler, G; Troppmair, J; Kolch, W; Haller, M; Woelfler, A; Sill, H; Zebisch, A
RAF kinase inhibitor protein inhibits 1,25-dihydroxyvitamin D3 induced myelomonocytic differentiation of HL-60 acute myeloid leukemia cells.
memo-magazine of european medical oncology
2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Poster]
Wölfler, A; Rosenberger, A; Wolf, O; Zebisch, A; Touw, IP; Sill, H
A role of C/EBP-Alpha in Development of Plasmacytoid Dendritic Cells in the Thymus
Haematologica. 2014; 99(S1):174-174.-19th Congress of European Hematology Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
Zebisch, A; Wolf, O; Rosenberger, A; Petricevic, P; Hatzl, S; Troppmair, J; Kolch, W; Blyth, K; Haller, M; Sill, H; Woelfler, A
RAF kinase inhibitor protein is involved in the regulation of myelomonocytic differentiation.
Oncol Res Treat. 2014; 37(S5):49-49. 2014; 37(S5):24-24.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg. (ISBN: 978-3-318-0281 )
[Oral Communication]
Web of Science
Duettmann, W; Huber-Krassnitzer, B; Theiler, G; Raggam, RB; Prueller, F; Neumeister, P; Zebisch, A; Wagner, J; Seeber, K; Wölfler, A; Krause, R; Hoenigl, M.
Impact of Structured On-Site Patient Education on Low Posaconazole Plasma Concentrations.
. 2013; -53rdInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); SEP 10-13, 2013; Denver, USA.
[Oral Communication]
Duettmann, W; Koidl, C; Abdyli, L; Waitzl, B; Huber-Krassnitzer, B; Wagner, J; Schmidt, H; Troppan, K; Valentin, T; Wölfler, A; Krause, R; Hoenigl, M
Comparison of Galactomannan test from serum and urine specimens in patients with haematological malignancies: a cohort study
. 2013; -23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 27-30, 2013; Berlin, GERMANY.
[Oral Communication]
Duettmann, W; Koidl, C; Huber-Krassnitzer, B; Waitzl, B; Neumeister, P; Wagner, J; Seeber K; Sill H; Wölfler, A; Krause, R; Hoenigl, M
Serum and Urine Galactomannan Testing for Screening in Patients with Hematological Malignancies.
. 2013; -53 rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); SEP 10-13, 2013; Denver, USA..
[Poster]
Duettmann, W; Wagner, J; Huber-Krassnitzer, B; Schmidt, H; Raggam, RB; Neumeister, P; Valentin, T; Zollner-Schwetz, I; Wölfler, A; Krause, R; Hoenigl, M
Impact of structured personal on-site patient education on low Posaconazole plasma concentrations: a cohort study.
. 2013; -23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 27-30, 2013; Berlin, GERMANY.
[Poster]
Duettmann, W; Wagner, J; Raggam, RB; Huber-Krassnitzer, B; Cerewenka-Zinke W; Prueller, F; Koidl, C; Waitzl, B; Wölfler, A; Seeber, K; Valentin, T; Zollner-Schwetz, I; Buzina, W; Neumeister, P; Krause, R; Hoenigl, M
Comparision of Galactomannan and Beta-D-Glucan Serum Assays for Diagnosis of Invasive Fungal Infections in Hematologic Malignancy Patients.
. 2013; -53 rdInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); SEP 10-13, 2013; Denver, USA.
[Poster]
Hoenigl, M; Duettmann, W; Huber-Krassnitzer, B; Theiler, G; Raggam, RB; Prueller, F; Zebisch, A; Neumeister, P; Wagner, J; Seeber, K; Wolfler, A; Krause, R;
Impact of structured on-site patient education on low posaconazole plasma concentrations.
MYCOSES. 2013; 56: 47-47.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
[Oral Communication]
Web of Science
Hoenigl, M; Duettmann, W; Koidl, C; Buzina, W; Seeber, K; Wölfler, A; Wagner, J; Krause, R; Thornton, C
Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis: a cohort study
. 2013; -23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 27-30, 2013; Berlin, GERMANY.
[Oral Communication]
Hoenigl, M; Duettmann, W; Koidl, C; Buzina, W; Troppan, K; Wölfler, A; Fruhwald, S; Wagner, J; Seeber, K; Valentin T; Zollner-Schwetz, I; Thornton, C; Krause, R
Bronchoalveolar lavage lateral-flow device test for diagnosing invasive pulmonary aspergillosis.
. 2013; -7. Österreichischer Infektionskongress; APR 10-13, 2013; Saalfelden, AUSTRIA.
[Poster]
Hoenigl, M; Duettmann, W; Koidl, C; Waitzl, B; Sartori, B; Seeber, K; Lackner, M; Posch, V; Buzina, W; Wolfler, A; Krause, R; Thornton, C; Lass-Florl, C;
Bronchoalveolar lavage lateral-flow device test for diagnosing invasive pulmonary aspergillosis: a multicenter study.
MYCOSES. 2013; 56: 71-71.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
[Poster]
Web of Science
Hoenigl, M; Duettmann, W; Koidl, C; Waitzl, B; Sartori, B; Seeber, K; Lackner, M; Posch, V; Buzina, W; Wölfler, A; Krause, R; Thornton, C; Lass-Flörl, C.
Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis: a multicenter study.
. 2013; -53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); SEP 10-13, 2013; Denver, USA.
[Poster]
Hoenigl, M; Duettmann, W; Raggam, RB; Wölfler, A; Huber-Krassnitzer, B; Seeber, K; Fruhwald, S; Prueller, F; Wagner, J; Valentin, T; Zollner-Schwetz, I; Krause, R
Voriconazole Therapeutic Drug Monitoring in Hematological and ICU Patients: a cohort study.
. 2013; -7. Österreichischer Infektionskongress; APR 10-13, 2013; Saalfelden, AUSTRIA.
[Poster]
Hoenigl, M; Duettmann, W; Raggam, RB; Wölfler, A; Seeber, K; Frughwald, S; Wagner, J; Valentin, T; Zollner-Schwetz, I; Krause, R.
Voriconazole Therapeutic Drug Monitoring in Hematological and ICU Patients: a cohort study.
. 2013; -23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 27-30, 2013; Berlin, GERMANY.
[Oral Communication]
Hoenigl, M; Duettmann, W; Wagner, J; Raggam, RB; Huber-Krassnitzer, B; Cerewena-Zinke, W; Prueller, F; Koidl, C; Wolfler, A; Valentin, T; Zollner-Schwetz, I; Seeber, K; Buzina, W; Neumeister, P; Krause, R;
Comparision of galactomannan and beta-D-glucan serum assays for diagnosis of invasive fungal infections in hematologic malignancy patients.
MYCOSES. 2013; 56: 71-72.-6th Trends in Medical Mycology; OCT 11-14, 2014; Kopenhagen, DENMARK.
[Poster]
Web of Science
Hoenigl, M; Koidl, C; Duettmann, W; Huber-Krassnitzer, B; Waitzl, B; Neumeister, P; Posch, V; Seeber, K; Wagner, J; Sill, H; Wolfler, A; Krause, R;
Serum and urine galactomannan testing for screening in patients with hematological malignancies.
MYCOSES. 2013; 56: 85-85.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
Web of Science
Hoenigl, M; Seeber, K; Koidl, C; Buzina, W; Strenger V; Duettmann, W; Wagner, J; Wölfler, A; Krause, R.
Sensitivity of Galactomannan Enzyme Immunoassay for Diagnosing Breakthrough Invasive Aspergillosis under Antifungal Prophylaxis and Empirical Therapy
. 2013; -7. Österreichischer Infektionskongress; APR 10-13, 2013; Saalfelden, Austria.
[Poster]
Linkesch, W; Zinke-Cerwenka, W; Wölfler, A; Sill, H; Neumeister, P
Allogene Nabelschnurtransplantation mit niedrig-dosiertem ATG bei Erwachsenen / UCBT with low-dose ATG in adult patients
Onkologie. 2013; P460--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA.
[Oral Communication]
Linkesch, W; Zinke-Cerwenka, W; Wolfler, A; Still, H; Neumeister, P
UCBT with low-dose ATG in adult patients
ONKOLOGIE. 2013; 36: 127-128.
[Poster]
Web of Science
Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Valentin, A; Woelfler, A;Seeber, K; Strohmaier, A; Zollner-Schwetz, I; Sill H; Krause, R..
Impact of Testing Posaconazole Plasma Concentrations on Epidemiology of Antifungal Prophylaxis and Therapy in Patients with Hematologic Malignancies
. 2012; -5th Advances Against Aspergillosis; JAN 25-28, 2012; Istanbul, TURKEY.
[Poster]
Hoenigl, M; Valentin, T; Strenger, V; Koidl, C; Buzina, W; Seeber, K; Valentin, A; Wolfler, A; Raggam, RB; Zollner-Schwetz, I; Krause, R
Host factors for invasive fungal infection among patients with hematological malignancies
MYCOSES. 2012; 55: 249-249.-18th Congress of the International Society for Human and Animal Mycology 2012 (ISHAM 2012); JUN 11-15, 2012; Berlin, GERMANY.
[Poster]
Web of Science
Hoenigl, M; Valentin, T; Strohmeier, A; Strenger, V; Koidl, C; Valentin, A; Buzina, W; Seeber, K; Zollner-Schwetz, I; Wölfler, A; Krause, R.
Host Factors for Invasive Fungal Infection among Patients with Hematological Malignancies: a case control study
. 2012; -6. Österreichischer Infektionskongress; APR 18-21, 2012; Saalfelden, AUSTRIA.
[Poster]
Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wolfler, A; Zebisch, A; Olipitz, W; Geigl, JB; Berghold, A; Speicher, MR; Sill, H
Germ-line mutations in cancer predisposing genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
ONKOLOGIE. Onkologie. 2012; 35: 117-117.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 19-23, 2012; Stuttgart, GERMANY.
[Poster]
Web of Science
Sill H, Tinchon C, Hojas S, Horvath K, Wölfler A
AML: ein evidenzbasiertes SOP
Annual Meeting, Austrian Society of Haematology and Oncology; April 2012; Graz. 2012.
[Keynote lecture]
Unteregger, M; Valentin, A; Linkesch, W; Sill, H; Wölfler, A
Therapy-related myeloid neoplasms versus myeloid neoplasms following a primary malignancy treated with surgery alone.
Magazine of european medical oncology Suppl 01/12. 2012; 9-9.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2007; Graz, Austria.
[Poster]
Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Seeber, K; Strohmaier, A; Woelfler, A; Zollner-Schwetz, I; Linkesch, W; Krause, R.
Posaconazole Serum Levels And Invasive Fungal Infections In Patients With Hematologic Malignancies
Mycoses. 2011; 54(sup2):180-180.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 )
[Poster]
Web of Science
Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Strohmaier, A; Rohn, A; Seeber, K; Zollner-Schwetz, I; Woelfler, A; Krause, R
Risk Factors Associated With Low Posaconazole Plasma Concentrations And Impact of Measurement On Antifungal Prophylaxis And Therapy.
Mycoses. 2011; 54(sup2):90-90.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 )
[Poster]
Web of Science
Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Zollner-Schwetz, I; Rohn, A; Woelfler, A; Seeber, K; Grisold, AJ; Linkesch, W; Krause, R;
Posaconazole serum levels and invasive fungal infections in patients with hematologic malignancies
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria.
[Poster]
Hoenigl, M; Salzer, HJ; Seeber, K; Raggam, RB; Valentin, T; Valentin, A; Zollner-Schwetz, I; Strohmeier, A; Wölfler, A; Linkesch, W; Krause, R.
Posaconazole Plasma Concentrations in Patients with Hematologic Malignancies
. 2011; -2nd Workshop:
Medical Mycology: From Basic Science to Clinical Needs
; DEC 8-10, 2011; Vienna, AUSTRIA.
[Oral Communication]
Hoenigl, M; Salzer, HJ; Valentin, T; Rohn, A; Seeber, K; Woelfler, A; Strohmaier, A; Krause, R;
Impact Of Galactomannan Testing On Epidemiology Of Invasive Fungal Infection Among Patients With Hematologic Malignancies.
Mycoses. 2011; 54(sup2):145-145.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 )
[Poster]
Web of Science
Hoenigl, M; Salzer, HJ; Valentin, T; Seeber, K; Valentin, A; Wölfler, A; Strohmeier, A; Zollner-Schwetz, I; Raggam RB; Linkesch, W; Krause, R.
Impact of Galactomannan Testing on Epidemiology of Invasive Fungal Infection among Patients with Hematologic Malignancies
. 2011; -2nd Workshop:
Medical Mycology: From Basic Science to Clinical Needs
; DEC 8-10, 2011; Vienna, AUSTRIA.
[Oral Communication]
Hoenigl, M; Salzer, HJ; Valentin, T; Zollner-Schwetz, I; Rohn, A; Woelfler, A; Strohmaier, A; Seeber, K; Sill H; Linkesch, W; Grisold, AJ; Krause, R
Impact of galactomannan testing on epidemiology of invasive fungal infection among patients with hematologic
malignancies
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria.
[Poster]
Hoenigl, M; Salzer, HJ; Valentin, T; Zollner-Schwetz, I; Strohmaier, A; Grisold, AJ; Rohn, A; Woelfler, A; Seeber, K; Linkesch, W; Krause, R
Risk factors for invasive fungal infection
among patients with hematologic malignancies.
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria.
[Poster]
Pichler, M; Fried, I; Bodner, C; Hiden, K; Linkesch, W; Sill, H; Wölfler, A
EZH2-und IDH1/2-Mutationen bei Patienten mit Therapie-assoziierter akuter myeloischer Leukämie (t-AML )
Magazine of European Medical Oncology. 2011; 4(Sup1):12-13.
[Poster]
Schulz E, Rohn A, Hiden K, Wölfler A, Beham-Schmid C, Guelly C, Lackner H, Geigl J, Speicher M, Sill H
Germ-line mutations in the DNA damage response and repair genes BRCA1, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
Haematologica 2011. 2011; 96(S2):25--Annual Meeting of the European Hematology Association; JUNE 2011; London, UK.
[Poster]
Schulz, E; Rohn, A; Lind, K; Woelfler, A; Beham-Schmid, C; Guelly, C; Lackner, H; Geigl, J; Speicher, M; Sill, H
Keimbahnmutationen in den DNA-Reparatur und Apoptose-induzierenden Genen BRCA1, BARD1 und TP53 bei Patienten mit Therapie-assoziierten myeloischen Neoplasien.
OeGHO Frühjahrstagung (Young Investigator Meeting); MAY, 5-7, 2011; Pörtschach, AUSTRIA. 2011.
[Oral Communication]
Zebisch, A; Wölfler, A; Hiden, K; Bodner, C; Fried, I; Quehenberger, F; Drasche, A; Pirkebner, D; Rath, O; Blyth, K; Matallanas, D; Taskesen, E; Kolch, W; Troppmair, J; Sill, H
RAF and RKIP in Acute Myeloid Leukemia
Fruehjahrstagung 2011 der Oesterreichischen Gesellschaft fuer Haematologie & Onkologie; Mai 5-7, 2011; Poertschach, AUSTRIA. 2011.
[Oral Communication]
Zebisch, A; Wölfler, A; Hiden K; Bodner, C; Quehenberger, F; Drasche, A; Pirkebner, D; Haller, M; Matallanas, D; Fried, I; Rath, O; Blyth, K; Taskesen, E; Kolch, W; Troppmair, J; Sill, H
RAF kinase inhibitor protein ist ein neuer Tumor-Suppressor bei der akuten myeloischen Leukämie
Onkologie. 2011; 34(S6):209-209.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; SEP 30-OCT 4, 2011; Basel, Switzerland. (ISBN: 978-3-8055-9922-1 )
[Oral Communication]
Web of Science
FullText
Zinke-Cerwenka, W; Rohn, A; Posch, U; Beham-Schmid, C; Linkesch, W; Wölfler, A; Sill, H
Graft-versus-primary malignancy in patients with therapy-related myeloid neoplasms (t-MNs) undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT).
Onkologie. 2011; 34(6):274-274.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel.
[Poster]
Web of Science
Zinke-Cerwenka W, Rohn A, Posch U, Beham-Schmid C, Linkesch W, Wölfler A, Sill H.
Allogeneic stem cell transplantation with reduced intensity conditioning in patients with therapy-related myeloid neoplasms
European Surgery. 2011; 43, Suppl. 242: 22--Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oktober 2011; Graz.
[Oral Communication]
Bodner, C; Pichler, MM; Deutsch, AJ; Beham-Schmid, C; Linkesch, W; Sill, H; Wolfler, A
IDH mutations in therapy-related and secondary AML evolving from myelodysplastic syndromes.
ONKOLOGIE. 2010; 33: 232-233.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY.
[Poster]
Web of Science
Pichler, M; Bodner, C; Hiden, K; Linkesch, W; Sill, H; Wölfler, A
IDH1 and IDH2 mutations in patients with therapy-related and secondary AML evolving from myelodysplasia.
Memo2010; 3 Suppl. 01/10: 13--Jahrestagung der Österr. Gesellschaft für Hämatologie und Onkologie; Apri 2010; Bregenz.
[Poster]
Wolfler, A; Haanstra, J; Valkhof, M; Vroegindeweij, E; van Strien, P; Oorschot, ADV; Cupedo, T; Touw, I
C/EBPa INSTRUCTS EARLY THYMIC PROGENITORS TOWARDS CELLS WITH MYELOID AND DENDRITIC CELL POTENTIAL
HAEMATOL-HEMATOL J. 2010; 95: 0592
[Poster]
Web of Science
Zebisch, A; Woelfler, A; Hiden, K; Bodner, C; Quehenberger, F; Drasche, A; Pirkebner, D; Haller, M; Rath, O; Blyth, K; Taskesen, E; Kolch, W; Troppmair, J; Sill, H
Loss of RAF Kinase Inhibitor Protein Is a Frequent Event In Acute Myeloid Leukemia with a Monocytic Phenotype and Cooperates with Mutant RAS In Malignant Transformation
BLOOD. 2010; 116(21): 1702-1702.
[Poster]
Web of Science
Zebisch, A; Woelfler, A; Hiden, K; Bodner, C; Quehenberger, F; Drasche, A; Pirkebner, D; Rath, O; Blyth, K; Delwel, R; Taskesen, E; Kolch, W; Troppmair, J; Sill, H
LOSS OF RKIP IN ACUTE MYELOID LEUKEMIA WITH A MONOCYTIC PHENOTYPE
HAEMATOL-HEMATOL J. 2010; 95: 0026 -Annual Meting of the European Haematology Association; June 2010; Barcelona.
[Poster]
Web of Science
Zebisch, A; Haller, M; Hiden, K; Rath, O; Doyle, B; Wölfler, A; Delwel, R; Kolch, W; Troppmair, J; Sill, H
Loss of the tumor suppressor RKIP in acute myeloid leukemia
Memo2009; 2 (Suppl.2): -Frühjahrstagung der Österr. Gesellschaft für Hämnatologie und Onkologie; April 2009; Salzburg.
[Oral Communication]
Weingrill, E; Wölfler, A; Strunk, D; Emberger, W; Linkesch, W; Liebmann, PM;
Roscovitine induces apoptosis and shows synergistic activity with alemtuzumab in isolated B-CLL cells.
Wien Med Wscr. 2005; 155(117):20-20.
[Poster]
Zinke-Cerwenka, W; Neumeister, P; Eibl, M; Sill, H; Emberger, W; Wagner, T; Wolfler, A; Linkesch, W
Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
BONE MARROW TRANSPLANT 2005 35: S387-S388.
Web of Science
Eibl, M; Zinke-Cerwenka, W; Neumeister, P; Wolfler, A; Sill, H; Linkesch, W
Autologous stem cell transplantation for multiple myeloma in elderly patients
BONE MARROW TRANSPLANT 2004 33: S357-S357.
Web of Science
Neumeister,P; Strunk,D; Wölfler,A; Linkesch,W;
Pegfilgastrim shows safety and efficacy in patients undergoing autologous hematopoietic stem cell transplantation for hematological malignancies.
Acta Med Aust. 2004; 31(5):19-19.
[Poster]
Wölfler,A; Erkeland,S; Leitner,C; Olipitz,W; Bodner,C; Renner,W; Pfeilstöcker,M; Tinchon,C; Linkesch,W; Touw,IP, Sill,M;
Assoziation des funktionellen Glu785Lys Polymorphismus des G#CSF Rezeptors mit Hochrisiko-Myelodysplasie.
Acta Med Aust. 2004; 31: 8-8.
[Keynote lecture]
Wölfler,A;Ekkeland,S;;Bodner,C;Vakhof,M;Renner,W;Leitner,C;Olipitz,W;Pfeilstöcker,M;Tinchon,Ch;Emberger,W;Linkesch,W;Touw IP;Sill,H
A functional single nucleotide polymorphism of the GCSF receptor gene predisposes to high-risk myelodysplastic syndrome
99. Hämatologisch- Onkologischer Diskussionsabend; NOV 25 2004; Wien, Austria. 2004.
[Keynote lecture]
Zinke-Cerwenka, W; Neumeister, P; Sill, H; Emberger, E; Wagner, T; Wölfler, A; Eibl, M; Staber, P; Linkesch, W
Nonmyeloablative allogeneic peripheral stem cell transplantation following autograft for patients with newly diagnosed high-risk multiple myeloma
European Surgery 2004; 36(S200):25-25.- ; ; .
[Poster]
Wölfler, A; Erkeland, S; Leitner, C; Olipitz, W; Bodner, C; Renner, W; Pfeilstöcker, M; Tinchon, C; Linkesch, W; Touw, IP; Sill, H;
Assoziation des funktionellen Glu785Lys Polymorphismus des G-CSF Rezeptors mit Hochrisiko-Myelodysplasie.
Acta Med Aust. 2003; 31(5):8-8.- ; ; .
[Poster]
Wölfler, A; Erkeland, S; Leitner, C; Olipitz, W; Bodner, C; Wagner, T; Linkesch, W; Touw, IP; Sill, H
A functional polymorphism of the granulocyte colony-stimulating factor receptor is associated with increased risk of myelodysplastic syndrome.
BLOOD 2003 102: 915A-916A.
Web of Science
Auner,H.W; Tinchon,C; Sill,H; Wölfler,A; Sormann,S; Linkesch,W; Quehenberger,F; Halwachs-Baumann,G;
Serum Troponin T as an indicator of anthracycline cardiotoxicity in adults.
J Clin Oncol. 2002; 20: 289-289.-Annual Meeting ASCO; MAY 18-21,2002; Orlando,FLORIDA.
[Poster]
Auner,HW; Tinchon,C; Sormann,S; Wölfler,A; Linkesch,W; Quehenberger,F; Halwachs-Baumann,G; Sill,H;
Serum troponin T as an indicator of anthracycline cardiotoxicity in adults.
Acta Med Aust. 2001; 28: 10-10.- ; ; .
[Keynote lecture]
Wölfler,A; Olipitz,W; Tinchon,C; Auner;H;Hoefler,G; Linkesch,W; Sill,H;
Acute abdomen due to G-CSF treatment in a patient with myelodysplastic syndrome.
Onkologie. 2001; 24: 88-88.- ; ; .
[Poster]
Stevenson, JR; Liebmann, PM; Hörtner, M; Rinner, I; Felsner, P; Wölfler, A; Schauenstein, K
A twelve hour noradrenalin and propranolol treatment induces declines in leukocyte populations in rat blood, spleen, and lymph nodes.
Journal of Neuroimmunology1998; 90(1):A236--5th International Congress of the International Society of Neuroimmunology; Augt 23-27, 1998; Montreal, Canada.
[Poster]
Wölfler, A; Liebmann, PM; Caluba, HC; Dohr, G; Schauenstein, K
Evaluation of antioxidative features of melatonin in a lymphocyte model.
Journal of Neuroimmunology1998; 90(1):A244--5th International Congress of the International Society of Neuroimmunology ; August 23-27, 1998; Montreal, Canada.
[Poster]
Wölfler, A; Liebmann, PM; Schauenstein, K
Melatonin in pharmacological concentrations enhances Fas-induced apoptosis in Jurkat T cells possibly by a pro-oxidative effect.
Journal of Neuroimmunology1998; 90(1):A245--5th International Congress of the International Society of Neuroimmunology, ; Aug 23-27, 1998; Montreal, Canada.
[Oral Communication]